Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick-borne Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05300425
What this trial is testing

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

Who this might be right for
LeptospirosisHepatitis E Virus InfectionTularemia
University Hospital, Basel, Switzerland 258
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Not applicableUnknownNCT02328469
What this trial is testing

Aseptic Meningoencephalitis in Slovenia

Who this might be right for
Aseptic Meningitis
University Medical Centre Ljubljana 800
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableWithdrawnNCT04318925
What this trial is testing

Evaluation and Follow-up of People With Tick-borne Diseases

Who this might be right for
Lyme DiseaseTick-Borne Disease
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableLooking for participantsNCT07312474
What this trial is testing

Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

Who this might be right for
Human Anaplasmosis
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Not applicableLooking for participantsNCT06397794
What this trial is testing

Navigating Pregnancy and Parenthood With Lyme Disease

Who this might be right for
Lyme DiseasePost Treatment Lyme DiseaseChronic Lyme Disease+4 more
Children's National Research Institute 30
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Testing effectiveness (Phase 2)Study completedNCT05387083
What this trial is testing

A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Who this might be right for
Healthy Volunteer
Tarsus Pharmaceuticals, Inc. 30
Post-approval studies (Phase 4)Study completedNCT01562444
What this trial is testing

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Who this might be right for
Tick Borne EncephalitisVirus Diseases
GlaxoSmithKline 206
Not applicableStudy completedNCT00132327
What this trial is testing

Analysis of Lyme Disease Lesions

Who this might be right for
Erythema Migrans LesionsErythema Migrans
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Not applicableStudy completedNCT03371563
What this trial is testing

Erythema Migrans in Elderly

Who this might be right for
Lyme DiseaseErythema MigransElderly Infection
University Medical Centre Ljubljana 1,220
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Early research (Phase 1)Study completedNCT03020771
What this trial is testing

Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans

Who this might be right for
Crimean-Congo Hemorrhagic Fever
The Scientific and Technological Research Council of Turkey 60
Not applicableLooking for participantsNCT03956446
What this trial is testing

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Who this might be right for
Tick Borne Encephalitis
University Medical Centre Ljubljana 80
Not applicableLooking for participantsNCT04402086
What this trial is testing

Rheumatology Patient Registry and Biorepository

Who this might be right for
Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more
Yale University 5,000
Not applicableEnded earlyNCT03581279
What this trial is testing

Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel

Who this might be right for
Lyme Disease
T2 Biosystems 18
Next Page